Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Elon Musk’s Neuralink device Blindsight gets FDA breakthrough device designation
MobiHealth News September 19, 2024
Blindsight is an experimental implant aimed at restoring vision in individuals who have lost sight in both eyes.
Elon Musk’s brain-computer interface implant startup Neuralink has received FDA breakthrough device designation for Blindsight, an implant that aims to restore vision in individuals who are blind.
Blindsight implants a microelectrode array into the visual cortex of a person’s brain. The array then activates neurons, which then provide the individual with a visual image.
According to Musk, the Blindsight device will enable even those who have lost sight in both eyes and their optic nerve to see as long as their visual cortex is intact. It will even allow those blind from birth to see for the first time.
The visual cortex...
Today's Sponsors
Today's Sponsor